MARKSANS PHARMA
Back to Income Statement
|
MARKSANS PHARMA Last 5 Year Earnings Per Share (EPS) History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Adjusted EPS | ₹6.92 | ₹5.88 | ₹4.51 | ₹5.76 | ₹2.86 |
What is the latest Earnings Per Share (EPS) of MARKSANS PHARMA ?
Year | Earnings Per Share (EPS) |
---|---|
Mar2024 | ₹6.92 |
Mar2023 | ₹5.88 |
Mar2022 | ₹4.51 |
Mar2021 | ₹5.76 |
Mar2020 | ₹2.86 |
How is Earnings Per Share (EPS) of MARKSANS PHARMA Trending?
Years | Earnings Per Share (EPS) | % Change | |
---|---|---|---|
Mar2024 | ₹6.92 | 17.69 | |
Mar2023 | ₹5.88 | 30.38 | |
Mar2022 | ₹4.51 | -21.70 | |
Mar2021 | ₹5.76 | 101.40 | |
Mar2020 | ₹2.86 | - |
Compare Earnings Per Share (EPS) of peers of MARKSANS PHARMA
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
MARKSANS PHARMA | ₹11,746.9 Cr | -1.1% | -14.6% | 72.2% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹422,715.0 Cr | 0.3% | -2.6% | 36.7% | Stock Analytics | |
DIVIS LABORATORIES | ₹154,460.0 Cr | -1% | -0.5% | 60.8% | Stock Analytics | |
CIPLA | ₹115,271.0 Cr | -1.4% | -3.1% | 11.8% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹107,511.0 Cr | -3.8% | -4% | 15.3% | Stock Analytics | |
ZYDUS LIFESCIENCES | ₹99,189.5 Cr | 0.1% | 1.2% | 40.3% | Stock Analytics |
MARKSANS PHARMA Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
MARKSANS PHARMA | -1.1% |
-14.6% |
72.2% |
SENSEX | -0.9% |
-4.3% |
3.7% |
You may also like the below Video Courses